tRNA modifications in cancer: from molecular mechanisms to clinical translation

Cillian H Cheng1, Chi Chun Wong2

  • 1Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China. chenghc95@gmail.com.

Biomarker Research
|April 11, 2026
PubMed

Insights

Transfer RNA (tRNA) modifications are crucial in cancer, acting as biomarkers and therapeutic targets. Understanding their role in protein expression and cell phenotypes is key for clinical applications.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Transfer RNA (tRNA) modifications are diverse RNA modifications with critical cellular functions.
  • Defects in tRNA modifications and tRNA fragmentation are observed across various cancer types.
  • tRNA modification enzymes can act as oncogenes or tumor suppressors.

Purpose of the Study:

  • To summarize the current understanding of tRNA modifications in cancer.
  • To outline the translational and clinical implications of tRNA modifications for cancer diagnosis and treatment.
  • To discuss the influence of tRNA modifications on protein expression, molecular mechanisms, and cell phenotypes.

Main Methods:

  • Literature review and synthesis of existing research on tRNA modifications in cancer.
  • Analysis of mechanistic studies on tRNA modification enzymes in cancer initiation, progression, and therapy resistance.
  • Discussion of clinical implications and translational challenges.

Main Results:

  • tRNA modifications play vital roles in cancer initiation, progression, metastasis, metabolic rewiring, therapy resistance, and immune evasion.
  • tRNA modification enzymes have significant potential as oncogenes or tumor suppressors.
  • tRNA modifications influence target tRNA fate, protein expression, and cell phenotypes.

Conclusions:

  • tRNA modifications represent promising diagnostic and prognostic biomarkers in cancer.
  • Targeting tRNA modification machinery offers therapeutic potential for cancer treatment.
  • Overcoming hurdles in translating tRNA modification research into clinical practice is essential.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.5K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
56.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K